The Canada Periodontal Disease Treatment Market was valued at $79.68 Million in 2024 and projected to reach to $106.73 Million by 2029, representing a compound annual growth rate of 5.0%. Canada's periodontal disease treatment market is positioned for consistent growth over the forecast period, supported by an aging population with higher disease prevalence and increasing emphasis on preventive oral care.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Canada's periodontal disease treatment market reached $79.68 million in 2024 and is expected to grow to $106.73 million by 2029, representing a steady 5.0% CAGR driven by demographic and healthcare trends.
Canada's rapidly aging demographic, with seniors comprising an increasing share of the population, is driving higher incidence of periodontal disease and demand for specialized treatment services across provinces.
Rising public awareness campaigns and dental education initiatives across Canada are improving early detection and treatment-seeking behavior among adults, supporting market expansion.
Canada's robust dental healthcare system, provincial coverage programs, and integration with public health initiatives create a stable environment for periodontal treatment market growth.
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | AGGRESSIVE PERIODONTITIS (Disease) |
| Forecast Period | 2024–2029 |
| Growth Rate | CAGR of 5.9% from 2024 to 2029 |
| Largest Segment | NON-SURGICAL TREATMENT (Treatment) |
| Market Size Base Year (Billions) | ~USD 2.57 (2024) |
| Revenue Forecast (Billions) | ~USD 3.43 (2029) |
| Segments Covered | Product, Disease, Type, Treatment |
4 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| DENTSPLY SIRONA | United States | Public Company | Connected Technology Solutions,Essential Dental Solutions,Orthodontic and Implant Solutions, |
| ENVISTA HOLDINGS CORPORATION | United States | Public Company | Specialty Products & Technologies – Implants & Biomaterials,Specialty Products & Technologies – Orthodontics & Clear Aligners,Equipment & Consumables – Imaging, Software & Visualization, |
| HENRY SCHEIN, INC. | United States | Public Company | Global Distribution and Value-Added Services,Global Specialty Products,Global Technology, |
| BIOLASE, INC. | United States | Public Company | Waterlase all-tissue systems,Diode soft-tissue systems,Consumables, fibers, and handpieces, |
| NAKANISHI INC. | Japan | Public Company | Dental handpieces (air turbines, contra-angles, micromotors),Surgical and mobile dentistry systems,Dental lab, hygiene, and maintenance products, |
| A-DEC INC. | Switzerland | Public Company | Flexible placement (temporary staffing and contracting),Permanent placement and career transition,Outsourcing and engineering consulting, |
DENTSPLY SIRONA is a United States-based public company founded in 1877 with 14,000 employees. The company operates in the dental industry.
ENVISTA HOLDINGS CORPORATION is a United States-based public company founded in 2018 with 12,000 employees. The company operates in the dental industry.
HENRY SCHEIN, INC. is a United States-based public company founded in 1932 with 25,000 employees. The company operates in the dental industry.
BIOLASE, INC. is a United States-based public company founded in 1984 with 157 employees. The company operates in the dental industry.
NAKANISHI INC. is a Japan-based public company founded in 1930 with 2,204 employees. The company operates in the dental industry.
A-DEC INC. is a Switzerland-based public company founded in 1957 with 33,569 employees. The company operates in the dental industry.
Canada's periodontal disease treatment market was valued at $79.68 million in 2024.
Canada's periodontal disease treatment market is projected to reach $106.73 million by 2029.
Canada's periodontal disease treatment market is growing at a compound annual growth rate of 5.0% from 2024 to 2029.
Canada's market growth is driven by an aging population, increased oral health awareness, strong dental insurance coverage, and adoption of advanced treatment technologies.
Canada's 5.0% CAGR is slightly below the global average of 5.9%, reflecting a mature but stable market with consistent healthcare infrastructure support.
Full forecast, segment splits, and company analysis for all Periodontal Disease Treatment Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report